Company Data
Tempest Therapeutics Inc.
Ticker
TPST
Current Price
$3.27 8.1%
Market Cap
$16.1M
Price Target
Refer to Report
Volume
263.4K
52wk Range
$3 - $13.65
Overview
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.